Lipidor Investor Relations Material
Latest events
Q4 2024
28 Feb, 2025
Q2 2024
28 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lipidor
Access all reports
Lipidor AB is a Swedish company based in Stockholm that specializes in developing topical treatments utilizing unique lipid-based formulations. Their primary focus is on creating formulations for psoriasis treatments. The company leverages its proprietary AKVANO technology, which enables the formation of a lipid layer on the skin surface, facilitating effective drug delivery and skin care treatments. Lipidor collaborates with various global pharmaceutical companies, providing formulation concepts and technologies aimed at improving patient quality of life. They manage the entire development process from preclinical stages to clinical trials, often partnering with external companies for manufacturing and clinical studies. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
LIPI
Country
🇸🇪 Sweden